Qvanteq AG is a pioneering brand that specializes in developing innovative biofunctional surfaces to address and overcome the adverse effects commonly associated with medical devices and vascular stents. With their state-of-the-art Qstent technology, Qvanteq aims to minimize thrombus formation and accelerate healing, revolutionizing the field of medical devices. Founded in 2009, Qvanteq is a spin-off company from the prestigious Swiss Federal Institute of Technology (ETH) Zurich.

The brand has garnered recognition for its groundbreaking work and was awarded the CTI start-up label in 2012. Qvanteq is backed by private investors and operates from the Technopark in Zurich, Switzerland. Qvanteq's cutting-edge products and services extend beyond neurovascular and peripheral solutions to include coronary devices and other advanced medical technologies.

Additionally, the brand offers consulting services to guide and support the development of efficient and effective medical devices. With a commitment to reducing thrombogenicity and improving patient outcomes, Qvanteq leads the way in biofunctional surface solutions for the medical industry. Contact them today to learn more about their groundbreaking technology and explore how they can revolutionize your medical device